Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Oral Ketamine Trial on Post-Traumatic Stress Disorder

To see complete record on, please visit this link

Id: ACTRN12618001965291

Organisation Name: University of the Sunshine Coast Mind and Neuroscience Thompson Institute

Overal Status: Not yet recruiting

Start Date: 13/02/2020

Brief Summary: This study is an open-label, dose-ranging clinical trial aiming to explore the effectiveness, feasibility and tolerability of oral ketamine on post-traumatic stress disorder (PTSD). The pathology and neurobiology of PTSD will be examined via MRI and EEG as neurological measures. The Cambridge Neuropsychological Test Automated Battery. (CANTAB) will be used to measure cognitive functioning. The primary outcome of change in PTSD will be assessed using the CAPS-5 and PCL-5.

  • Australia

Total execution time in seconds: 0.15269088745117